JMPWA
XLRN

JP Morgan Private Wealth Advisors’s Acceleron Pharma XLRN Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,593
Closed -$618K – 2069
2021
Q3 		$618K Buy
3,593
+379
+12% +$49.6K ﹤0.01% 1418
2021
Q2 		$403K Sell
3,214
-191
-6% -$24.1K ﹤0.01% 1559
2021
Q1 		$462K Sell
3,405
-215
-6% -$27.8K ﹤0.01% 1344
2020
Q4 		$463K Sell
3,620
-31
-0.8% -$3.63K ﹤0.01% 1319
2020
Q3 		$411K Sell
3,651
-400
-10% -$39.8K ﹤0.01% 1235
2020
Q2 		$386K Sell
4,051
-338
-8% -$32.6K ﹤0.01% 1214
2020
Q1 		$394K Sell
4,389
-1,526
-26% -$119K ﹤0.01% 1025
2019
Q4 		$314K Buy
5,915
+95
+2% +$4.33K ﹤0.01% 1218
2019
Q3 		$230K Buy
+5,820
New +$252K ﹤0.01% 1294

JP Morgan Private Wealth Advisors's XLRN Position: Q4 2021 in Review

JP Morgan Private Wealth Advisors sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 3,593 shares — an estimated $618K sold.

JP Morgan Private Wealth Advisors first reported a position in XLRN in Q3 2019 and held it in 9 quarters. The position peaked at $618K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • JP Morgan Private Wealth Advisors reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 3,593 Acceleron Pharma shares in Q4 2021, an estimated $618K.
  • JP Morgan Private Wealth Advisors first reported a position in Acceleron Pharma in Q3 2019 and held it in 9 quarters.
  • JP Morgan Private Wealth Advisors's Acceleron Pharma position peaked at $618K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.